KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Accumulated Expenses (2016 - 2025)

Biogen (BIIB) has 17 years of Other Accumulated Expenses data on record, last reported at $2.8 billion in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses changed 0.18% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $2.8 billion, changed 0.18%, while the annual FY2025 figure was $2.8 billion, 0.18% changed from the prior year.
  • Other Accumulated Expenses reached $2.8 billion in Q4 2025 per BIIB's latest filing, up from $2.8 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.8 billion in Q3 2023 and bottomed at $2.2 billion in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $2.7 billion, with a median of $2.6 billion recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: grew 29.61% in 2022, then decreased 28.22% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $2.5 billion in 2021, then dropped by 0.54% to $2.5 billion in 2022, then grew by 4.05% to $2.6 billion in 2023, then rose by 7.02% to $2.8 billion in 2024, then fell by 0.18% to $2.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $2.8 billion in Q4 2025, $2.8 billion in Q3 2025, and $2.7 billion in Q2 2025.